eIRB 2 Launch and Information Sessions
September 3, 2013
The JHM IRB electronic research application system, eIRB, is being replaced by eIRB2. eIRB is almost ten years old, and has become increasingly problematic with slow processing, error messages and time outs. eIRB2 is built on the same software platform, but incorporates newer and more advanced technology.
We are planning to launch eIRB2 in late September. Prior to the launch eIRB will be taken off line for a few days to migrate data to eIRB2. Migration will occur over a weekend to minimize the impact on workflow. Users will be updated on the exact dates and times as testing for the new system is completed.
Most of the changes in eIRB2 are related to performance. However users will notice the following improvements:
- The recruitment and drugs/devices sections have been reworked to flow more smoothly.
- Questions in the Protocol Events section are redesigned to help researchers determine whether it is necessary to submit an event immediately or with the continuing review application.
- “Reviewer Notes” have replaced the “Respond to Issues” activity. This new activity will allow study teams to respond to IRB concerns directly in the relevant section of the application.
For more information about the changes in eIRB2 see http://www.hopkinsmedicine.org/institutional_review_board/about/eIRB/eirb2_launch.html .
For anyone interested in seeing a demonstration of eIRB2 and learning more about some of the changes three information sessions are scheduled prior to the eIRB2 launch date. These sessions are optional and will give users the opportunity to see some of the features prior to the launch.
- Wednesday, September 25th 3:00-4:00 p.m., Tilghman Auditorium (located off the Turner Concourse)
- Thursday, September 26th 1:00-2:30 p.m., Bayview Campus Asthma and Allergy Center, Carroll Auditorium
- Friday, September 27th 10:00-11:00 a.m., Tilghman Auditorium (located off the Turner Concourse)
The eIRB system has become an essential component for conducting clinical research at Johns Hopkins. I’d like to thank you in advance for your patience while the transition is taking place. We are hopeful the transition to eIRB2 will be smooth, and we are confident the users will be pleased with the end product.
Daniel E. Ford, M.D., M.P.H.
Vice Dean for Clinical Investigation